Delivery Order SPE2DB20D1050-SPE2DB25FH91K
- Not listed
- The Defense Logistics Agency awarded a $2,380.63 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Refresh Plus 0.5% eye drops in unit dose packaging (70 units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and a completion date of August 28, 2025. The order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $20,829.15 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for Refresh Plus 0.5% eye drops (30-count units). This is a firm fixed-price, competitively awarded contract with a completion date of September 15, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,396.57 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 units) on July 21, 2025, with completion scheduled for July 22, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency awarded a $2,845.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units) with a completion date of September 17, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.92 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops UD 70s, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a routine pharmaceutical supply delivery under the company's broader federal medical procurement portfolio. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $1,108.80 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Refresh Plus 0.5% eye drops (30 units). This firm fixed price, non-set-aside contract is scheduled for completion by August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical Supply Chain operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.94 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on September 12, 2025, with a completion date of September 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger prime contract vehicle with DLA. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,889.08 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (50-count unit dose) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,290.00 for Refresh Plus 0.5% eye drops (30-unit package) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract has no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,933.22 to AmerisourceBergen Drug Corp for Refresh Plus 0.5% Eye Drops (30 count) on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH91KDelivery Order
The Defense Logistics Agency awarded a $1,740.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Refresh Plus 0.5% eye drops (30-count units). Issued on September 16, 2025, with an ultimate completion date of September 17, 2025, this competitively awarded contract required no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a prime vendor on this contract vehicle, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The firm's federal procurement portfolio demonstrates substantial capability in delivering competitively awarded medical commodities ranging from small-value transactions to substantial orders, supporting military and veteran healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/16/25 |